共 110 条
[1]
Brandberg Y(2003)Quality of life in women with breast cancer during the first year after random assignment to adjuvant treatment with marrow supported high-dose chemotherapy with cyclophosphamide, thiotepa, and carboplatin or tailored therapy with fluorouracil, epirubicin, and cyclophosphamide: Scandinavian Breast Group Study 9401 Journal of Clinical Oncology 21 3659-3664
[2]
Michelson H(1993)Risk adjustment in outcome assessment: The Charlson Comorbidity Index Methods of Information in Medicine 32 382-387
[3]
Nilsson B(2014)Physical and psychosocial problems in cancer survivors beyond return to work: A systematic review Psycho-Oncology 23 481-492
[4]
Bolund C(2011)Quality of life in breast cancer patients during chemotherapy and concurrent therapy with a mistletoe extract Phytomedicine 18 151-157
[5]
Erikstein B(1992)The Nottingham Prognostic Index in primary breast cancer Breast Cancer Research and Treatment 22 207-219
[6]
Hietanen P(2011)Physical and psychosocial recovery in the year after primary treatment of breast cancer Journal of Clinical Oncology 29 1101-1109
[7]
D’Hoore W(2012)Prolonged impact of chemotherapy on fatigue in breast cancer survivors Cancer 118 3833-3841
[8]
Sicotte C(2010)Quality of life, anxiety, and oncological factors: A follow-up study of breast cancer patients Psychosomatics 51 112-123
[9]
Tilquin C(2010)Personality traits and psychosocial stress: Quality of life over 2 years following breast cancer diagnosis and psychological impact factors Psychooncology 19 160-169
[10]
Duijts SFA(2011)Quality of life and toxicity in breast cancer patients using adjuvant TAC (docetaxel, doxorubicin, cyclophosphamid), in comparison with FAC (doxorubicin, cyclophosphamide, 5-fluorouracil) Archives of Gynecology and Obstetrics 284 215-220